Cytoprotective and Antioxidants in Peroxisomal Neurodegenerative Diseases
Several of the peroxisomal neurodegenerative disorders are the consequence of a specific deficiency of an enzyme or a transporter involved in peroxisomal beta-oxidation of very long chain fatty acids [1,2]. One of the hallmarks in these peroxisomal rare neurodegenerative diseases and in other common...
Tallennettuna:
| Päätekijät: | , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2019-04-01
|
| Sarja: | Proceedings |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/2504-3900/11/1/33 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|